Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Gilli

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 6, 2021
Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosisKrista D DiSano, Francesca Gilli, Andrew R Pachner
Plos One|July 29, 2016
High-Resolution Diffusion Tensor Spinal Cord MRI Measures as Biomarkers of Disability Progression in a Rodent Model of Progressive Multiple SclerosisFrancesca Gilli, Xi Chen, Andrew R Pachner, et al.
Frontiers in Molecular Neuroscience|October 31, 2022
Theiler's virus-induced demyelinating disease as an infectious model of progressive multiple sclerosisSteven C Pike, Nora Welsh, Michael Linzey, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 21, 2018
Clinical utility of a molecular signature in inflammatory demyelinating diseaseAndrew R Pachner, Krista DiSano, Darlene B Royce, et al.
Frontiers in Immunology|August 12, 2022
Divergent complement system activation in two clinically distinct murine models of multiple sclerosisMichael Linzey, Krista DiSano, Nora Welsh, et al.
Biomolecules|January 8, 2025
CXCL13 as a Biomarker: Background and Utility in Multiple SclerosisAndrew R Pachner, Steven Pike, Andrew D Smith, et al.
Journal of Neuroimmunology|November 21, 2017
Pegylated interferon beta in the treatment of the Theiler's murine encephalomyelitis virus mouse model of multiple sclerosisFrancesca Gilli, Darlene B Royce, Krista D DiSano, et al.
Multiple Sclerosis and Related Disorders|February 6, 2025
The CXCL13 index biomarker predicts success or failure of moderate-efficacy disease-modifying therapies in multiple sclerosis; A real-world studyAndrew R Pachner, Steven C Pike, Andrew D Smith, et al.
Frontiers in Immunology|August 21, 2019
Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple SclerosisKrista D DiSano, Darlene B Royce, Francesca Gilli, et al.
NPJ Parkinson'S Disease|January 11, 2024
Immunological shifts during early-stage Parkinson's disease identified with DNA methylation data on longitudinally collected blood samplesSteven C Pike, Matthew Havrda, Francesca Gilli, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 6, 2021
Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosisKrista D DiSano, Francesca Gilli, Andrew R Pachner
Plos One|July 29, 2016
High-Resolution Diffusion Tensor Spinal Cord MRI Measures as Biomarkers of Disability Progression in a Rodent Model of Progressive Multiple SclerosisFrancesca Gilli, Xi Chen, Andrew R Pachner, et al.
Frontiers in Molecular Neuroscience|October 31, 2022
Theiler's virus-induced demyelinating disease as an infectious model of progressive multiple sclerosisSteven C Pike, Nora Welsh, Michael Linzey, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 21, 2018
Clinical utility of a molecular signature in inflammatory demyelinating diseaseAndrew R Pachner, Krista DiSano, Darlene B Royce, et al.
Frontiers in Immunology|August 12, 2022
Divergent complement system activation in two clinically distinct murine models of multiple sclerosisMichael Linzey, Krista DiSano, Nora Welsh, et al.
Biomolecules|January 8, 2025
CXCL13 as a Biomarker: Background and Utility in Multiple SclerosisAndrew R Pachner, Steven Pike, Andrew D Smith, et al.
Journal of Neuroimmunology|November 21, 2017
Pegylated interferon beta in the treatment of the Theiler's murine encephalomyelitis virus mouse model of multiple sclerosisFrancesca Gilli, Darlene B Royce, Krista D DiSano, et al.
Multiple Sclerosis and Related Disorders|February 6, 2025
The CXCL13 index biomarker predicts success or failure of moderate-efficacy disease-modifying therapies in multiple sclerosis; A real-world studyAndrew R Pachner, Steven C Pike, Andrew D Smith, et al.
Frontiers in Immunology|August 21, 2019
Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple SclerosisKrista D DiSano, Darlene B Royce, Francesca Gilli, et al.
NPJ Parkinson'S Disease|January 11, 2024
Immunological shifts during early-stage Parkinson's disease identified with DNA methylation data on longitudinally collected blood samplesSteven C Pike, Matthew Havrda, Francesca Gilli, et al.
Pageof 5